Clinical trial
Hormone Therapy and OGX-011 Before Radical Prostatectomy in Treating Patients…
NCT00054106 · NCIC Clinical Trials Group, Other · Completed
Key facts
| NCT number | NCT00054106 |
|---|---|
| Title | Hormone Therapy and OGX-011 Before Radical Prostatectomy in Treating Patients With Prostate Cancer |
| Official title | A Phase I Study Of Combination Neoadjuvant Hormone Therapy And Weekly OGX-011 (Clusterin Antisense Oligonucleotide) Prior To Radical Prostatectomy In Patients With Localized Prostate Cancer |
| Lead sponsor | NCIC Clinical Trials Group, Other |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Prostate Cancer |
| Intervention type | Drug, Procedure |
| Interventions | buserelin, custirsen sodium, flutamide, conventional surgery, neoadjuvant therapy |
| Enrollment | 25 |
| Start date | Dec 10, 2002 |
| Primary completion | Sep 23, 2004 |
| Completion | Sep 22, 2008 |
| First posted | Feb 6, 2003 |
| Last update posted | Aug 4, 2023 |
| Countries | Canada |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: